New generic blood thinner put to the test in healthy volunteers
NCT ID NCT07517289
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks if a new generic version of the blood thinner enoxaparin works the same as the brand-name drug Clexane. About 26 healthy adults will receive a single dose of each drug, one week apart, and have their blood tested. The goal is to see if the generic is a safe and effective alternative.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injectable drug safely tackle weight? an early trial seeks answers
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Scientists map brain changes during Hour-Long DMT experience
- First human trial launches for experimental drug BY002
- New drug BW-50218 put to first safety test in healthy chinese volunteers
- New COPD drug candidate AN01 begins first human safety tests